Varex Q4 revenue $229M (+11% YoY); Non-GAAP EPS $0.37; guides Q1 $200-215M

Varex Imaging Corp

2025-FY EPS reported -$1.70 revenue$844,600,000

Q4 FY25 revenue $229M, up 11% YoY; Medical segment $152M (+5%), Industrial $77M (+25%).
GAAP diluted EPS $0.29; Non-GAAP diluted EPS $0.37, up from $0.19 in Q4 FY24.
FY25 revenue $845M (+4% YoY); Non-GAAP EPS $0.90 (+73%); Non-GAAP EBITDA $122M (+37%).
Cash & securities $155M at FY25 end, down from $213M due to convertible debt paydown in June 2025.
Q1 FY26 guidance: revenue $200-215M, Non-GAAP EPS $0.05-0.25.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.